Tips for Dosage Forms & Drug Delivery Systems

The symptoms of E&L failure in dental gel manufacturing may manifest in various forms, often caught during Quality Control (QC) testing or through unexpected findings from the field. Common signals…

The first step in addressing fill weight variability is recognizing the symptoms or signals that indicate a potential issue. Symptoms may include:Click to read the full article.

Symptoms of viscosity drift may manifest as unexpected changes in product texture, flow, or stability. Manufacturing teams and quality control laboratories should be vigilant for the following signals:Click to read…

In the realm of pharmaceutical manufacturing, especially concerning dental paste fillings, complaints regarding texture grittiness can manifest through a variety of symptoms and signals. These may include:Click to read the…

Detecting microbial limits failures typically starts with observing deviations from expected results during stability testing. Common symptoms or signals may include:Click to read the full article.

Identification of signals is critical to preemptively addressing assay OOS incidents. Symptoms may manifest in various forms, including but not limited to:Click to read the full article.

Texture grittiness can manifest during various stages of pharmaceutical development and production, particularly observed during accelerated stability testing. Key symptoms include:Click to read the full article.

Identifying symptoms of microbial limits failure can occur at various stages of the manufacturing process. Symptoms may include:Click to read the full article.

Identifying symptoms associated with assay OOS results is the first critical step in any deviation investigation. Symptoms may manifest as discrepancies in assay results compared to the expected specifications defined…